We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nordea Investment Management
326
Nordea Investment Management
Sweden
$165K – – –
EOJOAM
327
E. Ohman J:or Asset Management
Sweden
$163K – – –
SBL
328
Sargent Bickham Lagudis
Colorado
$152K – – –
Envestnet Asset Management
329
Envestnet Asset Management
Illinois
$149K -$954K -7,502 -88%
ASN
330
Advisory Services Network
Georgia
$141K -$17.2K -135 -12%
FWM
331
Focused Wealth Management
New York
$139K +$119K +940 New
PK
332
Pflug Koory
Nebraska
$129K -$19.1K -150 -15%
AG
333
Advisor Group
Arizona
$123K +$11.1K +87 +12%
SWP
334
Stratos Wealth Partners
Ohio
$120K +$103K +814 New
BTIS
335
BB&T Investment Services
North Carolina
$111K – – –
LTFS
336
Ladenburg Thalmann Financial Services
Florida
$96K +$7.5K +59 +10%
HNB
337
Huntington National Bank
Ohio
$95K – – –
OWA
338
One Wealth Advisors
California
$92K +$78.9K +621 New
OSAM
339
O'Shaughnessy Asset Management
Connecticut
$90K -$2.56M -20,174 -97%
MPPLM
340
Midwest Professional Planners Ltd (MPPL)
Wisconsin
$84K +$72.1K +567 New
SO
341
STRS Ohio
Ohio
$75K -$14.1K -111 -18%
TRCT
342
Tower Research Capital (TRC)
New York
$70K +$37.1K +292 +161%
CG
343
Cutler Group
California
$68K -$409K -3,219 -87%
AssetMark Inc
344
AssetMark Inc
California
$62K -$381 -3 -0.7%
OMCS
345
Old Mutual Customised Solutions
South Africa
$59K – – –
MA
346
MUFG Americas
New York
$49K – – –
Parallax Volatility Advisers
347
Parallax Volatility Advisers
California
$46K +$33.4K +263 +548%
IDBONY
348
Israel Discount Bank of New York
New York
$43K -$3.18K -25 -8%
IA
349
IFP Advisors
Florida
$41K – – –
AW
350
Alpha Windward
Massachusetts
$40K +$25.8K +203 +303%
12 13
14
15 16

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.